)
Coherus Oncology (CHRS) investor relations material
Coherus Oncology Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual Meeting convened on May 27, 2026, with a quorum present to address several proposals.
Voting completed on Proposals 1, 2, 3, and 5; Proposal 4 required adjournment for further vote counting.
Meeting adjourned and scheduled to reconvene on May 29, 2026, specifically to finalize voting on Proposal 4.
Voting matters and shareholder proposals
Proposal 4 concerns reducing the exercise price of certain outstanding stock options.
Approval of Proposal 4 requires a majority of shares cast, excluding abstentions and broker non-votes.
If approved, eligible options will be repriced to the closing trading price on May 29, 2026, and their term extended by 10 years.
Early termination or exercise before May 29, 2027, will revert the exercise price to the original amount.
Board of directors and corporate governance
The board or compensation committee retains discretion to determine exceptions regarding option repricing.
- All proposals passed except the stock option price reduction, which was adjourned.CHRS
AGM 202627 May 2026 - LOQTORZI sales surged 61% year-over-year as net losses narrowed and cash reserves remained strong.CHRS
Q1 202618 May 2026 - Key vote on repricing employee stock options set for May 27, 2026 annual meeting.CHRS
Proxy filing5 May 2026 - Five key proposals, including director elections and equity plan changes, up for shareholder vote.CHRS
Proxy filing20 Apr 2026 - Shareholders to vote on repricing employee stock options at the May 2026 virtual meeting.CHRS
Proxy filing14 Apr 2026 - Shareholders will vote on director elections, auditor ratification, compensation, and equity plan changes.CHRS
Proxy filing9 Apr 2026 - Rapid oncology pipeline progress and strong LOQTORZI sales drive growth and pivotal trial plans.CHRS
The Citizens Life Sciences Conference 202610 Mar 2026 - LOQTORZI sales doubled, debt slashed, and key oncology trials advance toward 2026 data.CHRS
Q4 20259 Mar 2026 - Strong oncology focus, robust pipeline, and accelerating LOQTORZI sales drive future growth.CHRS
TD Cowen 46th Annual Health Care Conference4 Mar 2026
Next Coherus Oncology earnings date
Next Coherus Oncology earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage